Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study marzo 12, 2022enero 6, 2023
COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression febrero 25, 2016octubre 7, 2022
Effects of brain asymmetry on clinical manifestations and quality of life in Parkinson´s disease octubre 25, 1920octubre 25, 2022
Network analysis of the Parkinson´s disease questionnaire 39: new opportunities to develop effective interventions for better quality of life. diciembre 27, 1919diciembre 27, 2022
The Impact of Non-Motor Symptoms on Health-Related Quality of Life in Parkinson´s Disease: A Network Analysis Approach. diciembre 27, 1919diciembre 27, 2022
Changes in principal caregiver mood affects the mood of the Parkinson disease patient. The vicious cycle of illness. diciembre 27, 1919enero 25, 2023
Prevalence and factors associated with drooling in Parkinson´s disease. Results from a longitudinal prospective cohort and comparison with a control group. diciembre 27, 1919diciembre 27, 2022
Risk of Cognitive Impairment in Parkinson´s Disease Patients with Visual Hallucinations and Subjective Cognitive Complaints. diciembre 27, 1919enero 25, 2023
Clinical and structural brain correlates of hypomimia in early-stage Parkinson’s disease. diciembre 27, 1919diciembre 27, 2022
Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson’s disease patients. diciembre 27, 1919diciembre 27, 2022
